Actavis New Zealand

A Bold New Allergan

Actavis plc (NYSE: ACT) is focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world.

Actavis New Zealand is committed to providing pharmacists with long-term sustainable value across a broad product portfolio. This commitment is based on a partnership approach with pharmacists with value, choice, service & support central to the company’s offering.


News Archive

Truly Global

Now we have the global resource to bring the best possible generic options to New Zealand.

We have an industry leading global product portfolio of more than 750 molecules offered in more than 1,700 different combinations and dosage forms through our global operations, which includes all significant drug delivery technologies.

Find more





Arrow Pharmaceuticals, now called Actavis

Prescription Medicines

Wider Access for more Patients Actavis has played a key part in enabling many pharmaceuticals to be fully funded for the first time; such as the Ava low dose oral contraceptive and Tolterodine for OAB patients intolerant of oxybutynin.

We ensure that more pharmaceuticals are made more readily available at a lower cost; such as the removal of the Special Authority for Lamotrigine, the funding of Tramadol and Sertraline and the significant price reduction on Venlafaxine.

Find more


Medicines that families can afford

ArrowCare is our umbrella brand for non-prescription medicines.

Generic medicines are now more popular as consumers realise that they can pay a lot less for the same active ingredient as the original brands.

Find more


NEW Profal

Finasteride 1mg
Treatment for Male Pattern Hair Loss
NEW Profal

Find more

Over The Counter Brands

Our range does not stop at medicines but includes health, beauty and dermatology products as well:

  • Crampeze
  • Dermalab skincare products
  • Find more